CVD risk in the moderate-to-low declining cardiovascular health (CVH) group was 9.96 times that of the persistently high CVH ...

Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...

Nearly 45% of women over the age of 20 are living with some form of cardiovascular disease. Over a woman's lifetime, their ...

Heart disease is already the world's leading cause of death, and the addition of a new, invisible pollutant could make ...

Longitudinal patterns of change in CVH through young adulthood were associated with the risk for incident CVD in later life.

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

This chart shows the share of respondents in a selection of countries who said they suffer from cardiovascular diseases.

Experts are calling it part of "a new form of cardiovascular disease prevention"—here's the science behind why.

Adults with worse cardiovascular-kidney-metabolic health are at an increased risk of developing psoriasis, especially in those with high genetic risk.

Heart disease is the No. 1 cause of death in the United States. These are the steps you need to take to reduce your risk.

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...